Tango Therapeutics, Inc. (TNGX)
24.63
+0.18
(+0.74%)
USD |
NASDAQ |
Sep 24, 16:00
24.97
+0.34
(+1.38%)
After-Hours: 06:42
Tango Therapeutics Gross Profit (Annual) : 60.10M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 60.10M |
| December 31, 2024 | 39.57M |
| December 31, 2023 | 34.11M |
| Date | Value |
|---|---|
| December 31, 2022 | 20.83M |
| December 31, 2021 | 35.08M |
| December 31, 2020 | 6.031M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Revolution Medicines, Inc. | -16.56M |
| Beam Therapeutics, Inc. | 117.45M |
| Erasca, Inc. | -3.107M |
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | -0.199M |